Clinical trial
Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching…
NCT00274001 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274001 |
|---|---|
| Title | Quality of Life and Changes in Metabolism of Lipids and Glucose After Switching to a Nevirapine-based Regimen in HIV+ Patients |
| Official title | An Open, Randomised, Multicentre, Comparative Trial, to Evaluate the Benefit of Switching From a PI-based Regimen to a Nevirapine-based Regimen on the Quality of Life, Patient Adherence, Patient's Perception of Fat Redistribution and Metabolic Changes, in HIV+ Patients Suffering From Fat… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Quality of Life |
| Intervention type | Drug |
| Interventions | Nevirapine |
| Enrollment | 158 |
| Start date | Sep 1, 2001 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Jan 10, 2006 |
| Last update posted | Nov 1, 2013 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: